Recent Developments in Transcatheter Aortic Valve Implantation
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 1085
Special Issue Editor
Special Issue Information
Dear Colleagues,
Aortic stenosis (AS) is a common heart valve disease that can lead to heart failure and death. For patients with AS, valve repair or replacement surgery has historically been the mainstay of treatment, given that medical treatments have no proven benefit. However, transcatheter aortic valve implantation (TAVI) is increasingly becoming a preferred treatment option when compared to surgery, particularly for patients at an advanced age or those with comorbidities, as recovery from the treatment is typically much quicker.
TAVI is a minimally invasive treatment, as biological valve implantation is performed percutaneously (on top of the diseased valve without its removal) via an intra-arterial sheath. This technology has evolved over the past 20 years to be equivalent in terms of safety and efficacy to aortic surgery with up to 10 years follow-up. There are also numerous advantages for patients and healthcare systems, including abbreviated hospitalisation periods for treatment, less perioperative discomfort, and quicker recovery times.
This Special Issue aims to promote academic exchanges, progress the field of TAVI, and promote the widespread application of this technology in the treatment of heart valve diseases, including in more complex patient cases and scenarios.
Dr. Edward James Frazer Danson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- transcatheter aortic valve implantation
- TAVI
- aortic valve stenosis
- interventional cardiac surgery
- heart valve disease